- Pagina principale
- Analisi delle app
- Biosimilar
- Biosimilar Vs. DRUGDOCS
Biosimilar vs. DRUGDOCS Utilizzo e statistiche
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- App Store di Apple
- A pagamento
- Settore Medico
Classifica degli store
- -
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
BiosimilarRanking a confronto con DRUGDOCS
Confronta la tendenza di classifica Biosimilar nei ultimi 28 giorni rispetto a DRUGDOCS
Biosimilar#132
Rank
Classifica Biosimilar vs. DRUGDOCS per paese a confronto
Confronta la tendenza di classifica Biosimilar nei ultimi 28 giorni rispetto a DRUGDOCS
Tutte le categorie
Nessun dato disponibile
Settore Medico
Fai confronti con qualsiasi sito con la nostra prova gratuita
Biosimilar VS.
DRUGDOCS
19icembre d, 2024